State Ledger
Company profile

IDEXX LABORATORIES INC /DE CIK 874716

Ticker
IDXX (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Westbrook, ME 04092-2041
Fiscal year end
2025 (FY)
Market Data
Close
$518.01
Change
+$4.87
Change %
0.95%
Volume
35,506

IDXX · trading date Oct 9, 2026 · previous close $513.14 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$4.30B
Net income
$1.06B
Total assets
$3.35B
Total liabilities
$1.75B
Stockholders' equity
$1.61B
Cash & equivalents
$180.07M
Operating income
$1.36B
Operating cash flow
$1.18B
Capital expenditures
$124.68M

Fiscal year 2025, via 10-K filed 2026-02-20. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
31.6%
Net margin
24.6%
Free cash flow
$1.06B
Free cash flow margin
24.6%
Liabilities / assets
52.1%
Equity / assets
47.9%
CapEx / revenue
2.9%
Operating cash flow / net income
1.12×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $4.30B $1.06B $3.35B $1.75B $1.61B
2024 $3.90B $887.87M $3.29B $1.70B $1.60B
2023 $3.66B $845.04M $3.26B $1.78B $1.48B
2022 $3.37B $679.09M $2.75B $2.14B $608.74M
2021 $3.22B $744.85M $2.44B $1.75B $689.99M
Company Details
SIC code
2835
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-09
Financials filed via
Form 10-K
filed 2026-02-20

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Westbrook, ME 04092-2041
ONE IDEXX DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:32 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Maine — Public Companies